cancer screening guideline

(redirected from Colorectal CA)

cancer screening guideline

Any guideline promulgated by an authoritative organisation (e.g., the American Cancer Society) for early detection of a malignancy which is common in a particular demographic, the diagnosis of which, if caught early, results in a complete cure or improved long-term survival.

Cancer screening guidelines
• Breast CA—Self-breast examination on a monthly basis, a baseline mammogram at age 40 and mammography every 1–2 years thereafter, depending on risk factors. 
• Colorectal CA—Per NCI, Am. Cancer Society, and Am. College of Physicians: annual feacal occult blood test > age 40 and flexible sigmoidoscopy every 3–5 years > age 50.
• Prostate CA—Annual digital rectal examination after age 40, and measurement of PSA in serum. 
• Uterine cervix—Annual Pap smear and pelvic examination after initiation of sexual activity; after 3 normal years, the test may be reduced in frequency at the discretion of the patient’s physician.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

cancer screening guideline

Any guideline promulgated by an authoritative organization–eg Am Cancer Society, for early detection of a malignancy common in a particular population, the diagnosis of which, if caught early, results in a complete cure or improved long-term survival. See Cancer screening, Cancer screening test; Cf Unproven methods for cancer management.
Cancer screening guidelines
Breast CA
Self-breast examination on a monthly basis, a baseline mammogram at age 40 and mammography every 1-2 years thereafter, depending on risk factors
Colorectal CA
Per NCI, Am Cancer Society, and Am College of Physicians–annual fecal occult blood test > age 40 and flexible sigmoidoscopy every 3-5 years > age 50 (NEJM 1991; 325:37)
Prostate CA
Annual digital rectal examination after age 40, and measurement of prostate-specific antigen or acid phosphatase in the serum
Uterine cervix
Annual Pap smear and pelvic examination after initiation of sexual activity; after 3 normal years, the test may be reduced in frequency at the discretion of the Pt's physician
.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
And what of the concerns regarding adenoma recurrences and colorectal CA? Adenomas are precancerous changes.
Using the manufacturers' decision values the following diagnostic sensitivities were obtained: Pancreatic CA: $2M 58.3%, CEA 37.5%, CA19-9 66.7%, CA195 100.0%, CA50 66.7%, CA242 66.7%, CA72-4 31.3%; Gastric CA: $2M 80.0%, CEA 50.0%, CA19-9 63.6%, CA195 58.3%, CA50 70.0%, CA242 70.0%, CA72-4 27.3%; Colorectal CA: $2M 28.4%, CEA 26.7%, CA19-9 18.8%, CA195 36.6%, CA50 18.2%, CA242 16.7%, CA72-4 17.0%.
Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA. Proc ASCO, 2004, 22, Abstr.